The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASH 2016 | Marginalized and high-risk multiple myeloma patients: how to address this issue
Joseph Mikhael, MD of the Mayo Clinic, Scottsdale, AZ talks about the issue of access to treatment for marginalized and high-risk multiple myeloma (MM) patients at the 2016 American Society of Hematology (ASH) Annual Meeting, held in San Diego, CA. Prof. Mikhael believes that it is important to be aware of the issue that some groups may be marginalized and make sure they have access to treatment. Further, we need to recognize that the myeloma community is a worldwide community and that experts should share their expertise.
